Recombinant human erythropoietin ameliorates cognitive dysfunction of APP/PS1 mice by attenuating neuron apoptosis via HSP90β

Signal Transduct Target Ther. 2022 May 6;7(1):149. doi: 10.1038/s41392-022-00998-w.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / genetics
  • Erythropoietin* / genetics
  • Erythropoietin* / pharmacology
  • Humans
  • Mice
  • Mice, Transgenic
  • Neurons
  • Presenilin-1

Substances

  • Presenilin-1
  • Erythropoietin